Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin

被引:14
作者
Kelso, EJ
Geraghty, RF
McDermott, BJ
Cameron, CHS
Nicholls, DP
Silke, B
机构
[1] Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT9 7BL, Antrim, North Ireland
[2] Queens Univ Belfast, Sch Clin Med, Belfast BT9 7BL, Antrim, North Ireland
[3] Royal Victoria Hosp Trust, Belfast BT9 7BL, Antrim, North Ireland
关键词
epirubicin; anthracycline; heart failure; cardiomyopathy; cardiomyocyte; beta-adrenoceptor;
D O I
10.1006/jmcc.1997.0563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to assess the structural, mechanical and electrophysiological changes associated with chronic administration of epirubicin (Pharmorubicin), which is a cardiotoxic anthracycline antibiotic used in conventional cancer chemotherapy, New Zealand white rabbits (8 weeks) were treated with twice-weekly infusions of epirubicin (2 mg/kg) or saline for a period of 6 weeks, followed by a wash-out period of 2 weeks. Myocardial damage consistent with cardiomyopathy was observed in the epirubicin-treated animals; electron micrographs indicated myofibril loss together with separation of the intercalated disc and dilation of the sarcotubular system. Contractile function, as measured by mechanical shortening, action potentials and L-type Ca2+ currents were examined in ventricular cardiomyocytes, which were isolated by means of enzymatic dissociation using collagenase. There was an attenuation in the contractile response to isoprenaline in cardiomyocytes isolated from the hearts of epirubicin-treated rabbits compared to control rabbits. Cardiomyocytes isolated from epirubicin-treated rabbits had greater basal contractile amplitude (11.0 +/- 0.3 %dL, n=8) than control myocytes (8.2 +/- 0.3 %dL, n=9), but had similar maximum responses of 19.1 +/- 0.6 %dL, and 17.3 +/- 0.5 %dL, respectively, when stimulated with 1 mu M isoprenaline. No differences were noted in the peak L-type Ca2+ current of myocytes isolated from the hearts of control and epirubicin-treated rabbits; however, in the latter, there was a prolongation of the action potential duration (396 +/- 25 ms) compared to that in controls (321 +/- 26 ms). These results demonstrate structural and mechanical alterations in ventricular cardiomyocytes which are compatable with a mild cardiomyopathy following chronic treatment with the anthracycline, epirubicin. The increase in basal contraction is likely to be due to more efficient coupling of electrical stimulation, and the depressed inotropic responsiveness following stimulation with isoprenaline indicates that there may be changes in cell membrane properties. Compared to control cardiomyocytes, cells isolated from the hearts of epirubicin-treated rabbits were more heterogeneous, with respect to cell dimensions, and had significantly different electromechanical properties. (C) 1997 Academic Press Limited.
引用
收藏
页码:3385 / 3397
页数:13
相关论文
共 49 条
[1]  
ARENA E, 1974, INT RES COMMUN SYS M, V2, P1053
[2]   ADRIAMYCIN CARDIOMYOPATHY IN THE RABBIT - AN ANIMAL-MODEL OF LOW OUTPUT CARDIAC-FAILURE WITH ACTIVATION OF VASOCONSTRICTOR MECHANISMS [J].
ARNOLDA, L ;
MCGRATH, B ;
COCKS, M ;
SUMITHRAN, E ;
JOHNSTON, C .
CARDIOVASCULAR RESEARCH, 1985, 19 (06) :378-382
[3]   ACUTE EFFECTS OF DOXORUBICIN ON SKINNED CARDIAC-MUSCLE FIBERS OF GUINEA-PIGS [J].
ASAYAMA, J ;
YAMAHARA, Y ;
TATSUMI, T ;
MIYAZAKI, H ;
INOUE, M ;
OMORI, I ;
INOUE, D ;
NAKAGAWA, M .
CARDIOVASCULAR RESEARCH, 1992, 26 (04) :371-375
[4]   ADRIAMYCIN CARDIOTOXICITY - POSSIBLE PATHOGENIC MECHANISMS [J].
AZUMA, J ;
SPERELAKIS, N ;
HASEGAWA, H ;
TANIMOTO, T ;
VOGEL, S ;
OGURA, K ;
AWATA, N ;
SAWAMURA, A ;
HARADA, H ;
ISHIYAMA, T ;
MORITA, Y ;
YAMAMURA, Y .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1981, 13 (04) :381-397
[5]  
BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865
[6]  
BOUCEK RJ, 1987, J BIOL CHEM, V262, P15851
[7]  
BRISTOW MR, 1982, HOSP PRACT, V17, P101
[8]  
BRISTOW MR, 1981, LAB INVEST, V45, P157
[9]   ADRIAMYCIN-INDUCED CHANGES TO THE MYOCARDIAL BETA-ADRENERGIC SYSTEM IN THE RABBIT [J].
CALDERONE, A ;
DECHAMPLAIN, J ;
ROULEAU, JL .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1991, 23 (03) :333-342
[10]   CELLULAR MECHANISMS OF VENTRICULAR FAILURE - MYOCYTE KINETICS AND GEOMETRY WITH AGE [J].
CAPASSO, JM ;
FITZPATRICK, D ;
ANVERSA, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (06) :H1770-H1781